Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Taro Pharm Inds (NY: TARO ) 42.97 UNCHANGED Last Price Updated: 7:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Taro Pharm Inds < Previous 1 2 Next > TARO Stock Earnings: Taro Pharmaceutical Indus Reported Results for Q4 2024 May 20, 2024 Taro Pharmaceutical Indus just reported results for the fourth quarter of 2024. Via InvestorPlace Earnings Scheduled For October 26, 2023 October 26, 2023 Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on revenue of $49.83 billion. Via Benzinga Taro Pharmaceutical Indus Earnings Preview October 25, 2023 Via Benzinga Why Shares of Taro Pharmaceutical Are Rising Tuesday May 30, 2023 The company is mulling a buyout offer from Sun Pharmaceutical. Via The Motley Fool Stocks That Hit 52-Week Lows On Wednesday March 15, 2023 On Wednesday, 479 stocks made new 52-week lows. Via Benzinga Taro Pharmaceutical Indus's Earnings Outlook January 23, 2023 Via Benzinga Earnings Scheduled For January 27, 2022 January 27, 2022 Companies Reporting Before The Bell • SAP (NYSE:SAP) is estimated to report quarterly earnings at $1.87 per share on revenue of $9.10 billion. •... Via Benzinga Earnings Scheduled For January 25, 2024 January 25, 2024 Companies Reporting Before The Bell • Nokia (NYSE:NOK) is projected to report quarterly earnings at $0.15 per share on revenue of $7.05 billion. Via Benzinga Earnings Preview For Taro Pharmaceutical Indus January 24, 2024 Via Benzinga Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 30, 2023 Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy. Via Benzinga Taro Pharmaceutical Indus's Earnings: A Preview October 26, 2022 Taro Pharmaceutical Indus (NYSE:TARO) is set to give its latest quarterly earnings report on Thursday, 2022-10-27. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga Taro Pharmaceutical Indus: Q1 Earnings Insights July 27, 2022 Taro Pharmaceutical Indus (NYSE:TARO) reported its Q1 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Via Benzinga Earnings Scheduled For January 24, 2023 January 24, 2023 Companies Reporting Before The Bell • GATX (NYSE:GATX) is expected to report quarterly earnings at $1.44 per share on revenue of $327.63 million. Via Benzinga Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy July 27, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Scheduled For October 27, 2022 October 27, 2022 Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million. Via Benzinga Stocks That Hit 52-Week Lows On Monday September 19, 2022 On Monday, 429 stocks made new 52-week lows. Via Benzinga Earnings Scheduled For July 27, 2022 July 27, 2022 Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter. Via Benzinga Stocks That Hit 52-Week Lows On Thursday May 26, 2022 On Thursday, 94 companies set new 52-week lows. Via Benzinga Taro Pharmaceutical Indus Earnings Preview May 25, 2022 Taro Pharmaceutical Indus (NYSE:TARO) is set to give its latest quarterly earnings report on Thursday, 2022-05-26. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More May 22, 2022 Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support. Via Benzinga Earnings Scheduled For May 26, 2022 May 26, 2022 Companies Reporting Before The Bell • American Woodmark (NASDAQ:AMWD) is likely to report quarterly earnings at $1.34 per share on revenue of $493.20 million. Via Benzinga 10 Biggest Price Target Changes For Monday January 31, 2022 Keybanc cut the price target on The Sherwin-Williams Company (NYSE: SHW) from $394 to $335. Sherwin-Williams shares rose 1.6% to close at $287.70 on Friday. Via Benzinga Stocks That Hit 52-Week Lows On Friday April 29, 2022 On Friday, 213 companies hit new 52-week lows. Via Benzinga The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron January 28, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Taro Pharmaceutical: Q3 Earnings Insights January 28, 2022 Taro Pharmaceutical Indus (NYSE:TARO) reported its Q3 earnings results on Thursday, January 27, 2022 at 04:00 PM. Here's what investors need to know about the... Via Benzinga The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study January 27, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance December 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus U.K. Signs Deal to Buy Incremental COVID-19 Vaccines From Moderna And Pfizer-... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug October 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In... Via Benzinga The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More October 24, 2021 Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts July 27, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI... Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.